Cargando…
Polydatin inhibits hepatocellular carcinoma via the AKT/STAT3-FOXO1 signaling pathway
Autores principales: | Jiang, Jian, Chen, Yaodong, Dong, Tianxiu, Yue, Minlu, Zhang, Yu, An, Tingting, Zhang, Jiuwei, Liu, Pengfei, Yang, Xiuhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812312/ https://www.ncbi.nlm.nih.gov/pubmed/31666816 http://dx.doi.org/10.3892/ol.2019.10856 |
Ejemplares similares
-
Polydatin inhibits hepatocellular carcinoma via the AKT/STAT3-FOXO1 signaling pathway
por: Jiang, Jian, et al.
Publicado: (2019) -
FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition
por: Dong, Tianxiu, et al.
Publicado: (2016) -
Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway
por: Li, Zizhuo, et al.
Publicado: (2019) -
Retraction Note: Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway
por: Li, Zizhuo, et al.
Publicado: (2023) -
Corrigendum: FOXO1 Alleviates Liver Ischemia-reperfusion Injury by Regulating the Th17/Treg Ratio through the AKT/Stat3/FOXO1 Pathway
Publicado: (2023)